BMC Gastroenterology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 23, 2024
Abstract
Background
Alterations
in
the
production
of
short-chain
fatty
acids
(SCFAs)
may
reflect
disturbances
gut
microbiota
and
have
been
linked
to
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD).
We
assessed
plasma
SCFAs
patients
with
MASLD
healthy
controls.
Methods
Fasting
venous
blood
samples
were
collected
eight
measured
using
gas
chromatography-tandem
mass
spectrometry
(GC-MS/MS).
Relative
between-group
differences
circulating
SCFA
concentrations
estimated
by
linear
regression,
relation
between
concentrations,
MASLD,
fibrosis
severity
was
investigated
logistic
regression.
Results
The
study
includes
100
(51%
mild/no
49%
significant
fibrosis)
50
Compared
controls,
had
higher
propionate
(21.8%,
95%
CI
3.33
43.6,
p
=
0.02),
formate
(21.9%,
6.99
38.9,
0.003),
valerate
(35.7%,
4.53
76.2,
α-methylbutyrate
(16.2%,
3.66
30.3,
0.01)
but
lower
acetate
(−
30.0%,
−
40.4
17.9,
<
0.001).
Among
positively
associated
(
butyrate
0.03),
0.02).
Six
significantly
increased
F4
fibrosis.
Conclusions
In
present
study,
severity,
further
research
is
needed
elucidate
potential
mechanisms
underlying
our
observations
assess
possible
benefit
therapies
modulating
microbiota.
Frontiers in Immunology,
Journal Year:
2020,
Volume and Issue:
11
Published: Oct. 16, 2020
The
gut
microbiota
has
been
linked
to
the
development
of
obesity
and
type
2
diabetes
(T2D).
underlying
mechanisms
as
how
intestinal
may
contribute
T2D
are
only
partly
understood.
It
becomes
progressively
clear
that
is
characterized
by
a
chronic
state
low-grade
inflammation,
which
insulin
resistance.
Here,
we
review
current
evidence
microbiota,
metabolites
they
produce,
could
drive
resistance
in
T2D,
possibly
initiating
an
inflammatory
response.
First,
will
summarize
major
findings
about
immunological
microbial
changes
these
metabolic
diseases.
Next,
give
detailed
view
on
have
implicated
inflammation.
Lastly,
critically
discuss
clinical
studies
focus
interaction
between
immune
system
disease.
Overall,
there
strong
tripartite
host
metabolism
critical
partaker
pathophysiology
T2D.
World Journal of Gastroenterology,
Journal Year:
2021,
Volume and Issue:
27(25), P. 3837 - 3850
Published: July 5, 2021
Obesity
is
a
major
global
health
problem
determined
by
heredity
and
environment,
its
incidence
increasing
yearly.
In
recent
years,
evidence
linking
obesity
to
the
gut
microbiota
has
been
reported.
Gut
management
become
new
method
of
treatment.
However,
complex
interactions
among
genetics,
microbiota,
remain
poorly
understood.
this
review,
we
summarize
characteristics
in
obesity,
mechanism
induced
influence
genetic
environmental
factors
on
provide
support
for
understanding
relationship
between
microbiota.
At
same
time,
prospect
research
related
proposed.
Molecular Neurodegeneration,
Journal Year:
2021,
Volume and Issue:
16(1)
Published: Feb. 8, 2021
Abstract
Background
Previous
studies
have
reported
that
gut
microbiota,
permeability,
short-chain
fatty
acids
(SCFAs),
and
inflammation
are
altered
in
Parkinson’s
disease
(PD),
but
how
these
factors
linked
they
contribute
to
processes
symptoms
remains
uncertain.
This
study
sought
compare
identify
associations
among
PD
patients
controls
elucidate
their
interrelations
links
clinical
manifestations
of
PD.
Methods
Stool
plasma
samples
data
were
collected
from
55
56
controls.
Levels
stool
SCFAs
inflammatory
permeability
markers
compared
between
related
one
another
the
microbiota.
Results
Calprotectin
was
increased
decreased
a
sex-dependent
manner.
Inflammatory
neither
intercorrelated
nor
strongly
associated
with
SCFA
levels.
Age
at
onset
positively
correlated
negatively
CXCL8
IL-1β
stool.
Fecal
zonulin
fecal
NGAL
motor
non-motor
symptoms.
Microbiota
diversity
composition
levels
SCFAs,
factors,
Certain
relationships
differed
by
sex.
Conclusions
Intestinal
responses
reductions
occur
PD,
microbiota
onset,
not
reflected
profiles.
Some
distinct
sex-dependent.
revealed
potential
alterations
microbiota-host
interactions
earlier
intestinal
reduced
levels,
highlighting
candidate
molecules
pathways
which
may
pathogenesis
presentation
warrant
further
investigation.
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(10), P. 2982 - 2982
Published: Sept. 29, 2020
Gut
microbiota
and
its
metabolites
such
as
short
chain
fatty
acids
(SCFA),
lipopolysaccharides
(LPS),
trimethylamine-N-oxide
(TMAO)
impact
cardiovascular
health.
In
this
review,
we
discuss
how
gut
can
affect
hypertension
atherosclerosis.
Hypertensive
patients
were
shown
to
have
lower
alpha
diversity,
abundance
of
SCFA-producing
microbiota,
higher
gram-negative
bacteria,
which
are
a
source
LPS.
Animal
studies
point
towards
direct
role
for
SCFAs
in
blood
pressure
regulation
show
that
LPS
has
pro-inflammatory
effects.
Translocation
into
the
systemic
circulation
is
consequence
increased
permeability.
Atherosclerosis,
multifactorial
disease,
influenced
by
through
multiple
pathways.
Many
focused
on
pro-atherogenic
TMAO,
however,
it
not
clear
if
causal
factor.
addition,
play
key
bile
acid
metabolism
some
interventions
targeting
receptors
tend
decrease
Concluding,
atherosclerosis
many
pathways,
providing
wide
range
potential
therapeutic
targets.
Challenges
ahead
include
translation
findings
mechanisms
humans
development
target
risk
modulation
microbes
metabolites.
Nutrients,
Journal Year:
2019,
Volume and Issue:
11(10), P. 2512 - 2512
Published: Oct. 18, 2019
There
have
been
mixed
results
regarding
the
relationship
among
short
chain
fatty
acids
(SCFAs),
microbiota,
and
obesity
in
human
studies.
We
selected
studies
that
provided
data
on
SCFA
levels
or
fecal
microbiota
abundance
obese
nonobese
individuals
then
combined
published
estimates
using
a
random-effects
meta-analysis.
Obese
had
significantly
higher
concentrations
of
acetate
(SMD
(standardized
mean
differences)
=
0.87,
95%
CI
(confidence
interva)
0.24–1.50,
I2
(I–squared)
88.5),
propionate
0.86,
0.35–1.36,
82.3%),
butyrate
0.78,
0.29–1.27,
81.7%)
than
controls.
The
subgroup
analyses
showed
no
evidence
heterogeneity
with
BMI
>30
kg/m2
(I2
0.0%).
At
phylum
level,
was
reduced
compared
to
individuals,
but
difference
not
statistically
significant
(Bacteroidetes
phylum,
SMD
−0.36,
−0.73–0.01;
Firmicutes
−0.10,
−0.31–0.10).
currently
available
case-control
show
is
associated
high
gut
richness
at
level.
Additional
well-designed
considerable
sample
size
are
needed
clarify
whether
this
association
causal,
it
also
necessary
identify
additional
contributors
production,
absorption,
excretion
humans.
Scientific Reports,
Journal Year:
2019,
Volume and Issue:
9(1)
Published: Aug. 29, 2019
Abstract
Microbial-derived
short-chain
fatty
acids
(SCFA)
acetate,
propionate
and
butyrate
may
provide
a
link
between
gut
microbiota
whole-body
insulin
sensitivity
(IS).
In
this
cross-sectional
study
(160
participants,
64%
male,
BMI:
19.2–41.0
kg/m
2
,
normal
or
impaired
glucose
metabolism),
associations
SCFA
(faecal
fasting
circulating)
circulating
metabolites,
substrate
oxidation
IS
were
investigated.
subgroup
(n
=
93),
was
determined
using
hyperinsulinemic-euglycemic
clamp.
Data
analyzed
multiple
linear
regression
analysis
adjusted
for
sex,
age
BMI.
Fasting
concentrations
positively
associated
with
GLP-1
concentrations.
Additionally,
negatively
related
to
lipolysis
(glycerol),
triacylglycerols
free
levels
(standardized
(std)
β
(adj)
−0.190,
P
0.023;
std
adj
−0.202,
0.010;
−0.306,
0.001,
respectively).
Circulating
acetate
were,
respectively,
correlated
(M-value:
−0.294,
<
0.001;
0.161,
0.033,
We
show
that
rather
than
faecal
concentrations,
peripheral
in
humans.
Therefore,
are
more
directly
linked
metabolic
health,
which
indicates
the
need
measure
human
prebiotic/probiotic
intervention
studies
as
biomarker/mediator
of
effects
on
host
metabolism.
Nutrients,
Journal Year:
2019,
Volume and Issue:
11(5), P. 1092 - 1092
Published: May 16, 2019
A
main
challenge
in
nutritional
studies
is
the
valid
and
reliable
assessment
of
food
intake,
as
well
its
effects
on
body.
Generally,
intake
measurement
based
self-reported
dietary
questionnaires,
which
have
inherent
limitations.
They
can
be
overcome
by
use
biomarkers,
capable
objectively
assessing
consumption
without
bias
assessment.
Another
major
goal
to
determine
biological
foods
their
impact
health.
Systems
analysis
dynamic
responses
may
help
identify
biomarkers
indicative
body
at
same
time,
possibly
relation
individuals’
health/disease
states.
Such
could
used
quantify
validate
analyse
physiological
or
pathological
certain
components
diets,
persons
with
specific
deficiency,
provide
information
inter-individual
variations
formulate
personalized
recommendations
achieve
optimal
health
for
particular
phenotypes,
currently
referred
“precision
nutrition.”
In
this
regard,
holistic
approaches
using
global
methods
(omics
approaches),
gathering
high
amounts
data,
appear
very
useful
new
enhance
our
understanding
role
disease.
Brain,
Journal Year:
2021,
Volume and Issue:
144(9), P. 2571 - 2593
Published: April 12, 2021
Parkinson's
disease
is
a
common
neurodegenerative
disorder
in
which
gastrointestinal
symptoms
may
appear
prior
to
motor
symptoms.
The
gut
microbiota
of
patients
with
shows
unique
changes,
be
used
as
early
biomarkers
disease.
Alterations
the
composition
related
cause
or
effect
non-motor
symptoms,
but
specific
pathogenic
mechanisms
are
unclear.
and
its
metabolites
have
been
suggested
involved
pathogenesis
by
regulating
neuroinflammation,
barrier
function
neurotransmitter
activity.
There
bidirectional
communication
between
enteric
nervous
system
CNS,
microbiota-gut-brain
axis
provide
pathway
for
transmission
α-synuclein.
We
highlight
recent
discoveries
about
alterations
focus
on
current
mechanistic
insights
into
pathophysiology.
Moreover,
we
discuss
interactions
production
α-synuclein
inflammation
neuroinflammation.
In
addition,
draw
attention
diet
modification,
use
probiotics
prebiotics
faecal
transplantation
potential
therapeutic
approaches
that
lead
new
treatment
paradigm
European Heart Journal,
Journal Year:
2020,
Volume and Issue:
41(44), P. 4259 - 4267
Published: Aug. 14, 2020
Preliminary
evidence
from
animal
and
human
studies
shows
that
gut
microbiota
composition
levels
of
microbiota-derived
metabolites,
including
short-chain
fatty
acids
(SCFAs),
are
associated
with
blood
pressure
(BP).
We
hypothesized
faecal
derived
metabolites
may
be
differently
BP
across
ethnic
groups.We
included
4672
subjects
(mean
age
49.8
±
11.7
years,
52%
women)
six
different
groups
participating
in
the
HEalthy
Life
In
an
Urban
Setting
(HELIUS)
study.
The
was
profiled
using
16S
rRNA
gene
amplicon
sequencing.
Associations
between
office
were
assessed
machine
learning
prediction
models.
subgroups
largest
associations,
SCFA
compared
200
lower
or
higher
systolic
BP.
Faecal
explained
4.4%
total
variance.
Best
predictors
for
Roseburia
spp.,
Clostridium
Romboutsia
Ruminococcaceae
spp.
Explained
variance
highest
Dutch
(4.8%),
but
very
low
South-Asian
Surinamese,
African
Ghanaian,
Moroccan
Turkish
descent
(explained
<0.8%).
levels,
acetate
(P
<
0.05)
propionate
0.01),
young
participants
BP.Faecal
is
BP,
strongly
divergent
associations
groups.
Intriguingly,
while
had
abundances
several
SCFA-producing
microbes,
they
levels.
Intervention
SCFAs
could
provide
more
insight
effects
these
on